M&E Intro1123112121 is about the monitoring.ppt

none

1. An Introduction to
Monitoring and Evaluation for
National TB Programs

2. Overview
What is monitoring and evaluation?
How can you use monitoring and
evaluation for program management?
Practical applications of monitoring and
evaluation

3. Definitions
Monitoringis the routine reporting of
data on program implementation and
performance
Evaluationis the periodicassessment
of program impact at the population
level and value

4. Monitoring
Has the program been implemented
according to the plan?
Are there any changes in program
resources or service utilization?
Are there any weaknesses in the
implementation of the program?
Where are the opportunities to
improve program performance?

5. Evaluation
Are there any changes in behavior or
health outcomes in the target
population?
To what extent are observed changes in
the target population related to
program efforts?

6. Monitoring vs. Evaluation
Level of measurement:
MonitoringData come from routinely
reported data
Example: Monthly service statistics
EvaluationData are measured at the
population level
Example: Prevalence of MDR-TB in
Country X

7. Why is M&E important for
National TB Programs?
To follow epidemiological trends in TB
To identify strengths and weaknesses in
program design and/or implementation
To address changing priorities
To convince policy makers of the need for
action and financial and human resources

8. Uses of M&E for program
management (1)
Informs decisions about program
operations and service delivery
Ensures effective and efficient use of
resources
Determine whether or not the program is
implemented according to plan

9. Uses of M&E for program
management (2)
Meets reporting requirements by different
agencies and sectors of government
Evaluates the extent to which the
program/project is having or has had the
desired impact

10. Practical applications (1)Over 17 million patients treated under
DOTS since 1995
0
10
20
30
40
50
60
70
80
1990 1995 2000 2005 2010 2015
Year
Case detection rate,
smear-positive cases
(%)
average rate of
progress 1995-2000
accelerated progress:
target 2005
Target 70%
DOTS begins

11. Practical applications (2)Prevalence and death rates are
falling, but not fast enough
0
100
200
300
400
19901992199419961998200020022004
Incidence or prevalence
rate (per 100,000)
0
5
10
15
20
25
30
35
Mortality rate
(per 100,000 per yr)
MDG targets
Prevalence
Deaths
Incidence
inc HIV+
exc HIV+
Case Case notification

12. Practical applications (3)Cost of TB control 2005: $1.3 billion
Budget gap 2005: $119 million
0%
20%
40%
60%
80%
100%
Sou th Afr ic a
Br az il
Vi et N am
R us si a
Phi li ppin es
T hail and
C hi na
D R C ongo
Indi a
T anz aniaIndon esi a
N ig eri a
Pak is tan
Ban glade sh
C ambo dia
Ken ya
Eth iopi a
Moz ambi que
Z imb abw e
My anmar
U ganda
Afg hanis tan
Percent of total costs
Government (excl. loans)LoansGrants (excl. GFATM)GFATM Gap

13. Practical applications (4)Cost-effectiveness of
community-based care in Uganda
391
911
0
200
400
600
800
1000
Conventional
hospital-based
care
Community-based
care
Cost per patient successfully
treated (US$)